Food and Drug Administration

• Drug manufacturer agrees to $500 million penalty

  By Eric Tucker  |  May 13, 2013

  A subsidiary of an Indian pharmaceutical company has agreed to pay $500 million fines and civil penalties for selling adulterated drugs and lying about tests to federal regulators.

• FDA wants cancer warnings on tanning beds

  By MATTHEW PERRONE  |  May 6, 2013

  Indoor tanning beds would come with new warnings about the risk of cancer and be subject to more stringent federal oversight under a proposal unveiled Monday by the Food and Drug Administration.

• Senate bill targets large compounding pharmacies

  By The Associated Press  |  April 26, 2013

  Large specialty pharmacies like the one that triggered a deadly meningitis outbreak last year would be subject to federal safety inspections and manufacturing standards, under a new Senate proposal introduced Friday.

• New York judge makes morning-after pill available to all

  By The Associated Press  |  April 5, 2013

  A New York federal judge has ruled that the Food and Drug Administration must make emergency contraceptives available to women of all ages within 30 days.

• 

  Five tips for saving on prescription drugs

  By Kathryn Mayer  |  April 1, 2013

  According to a Consumer Reports analysis, prescription drugs vary widely in price depending on where you shop. Here are tips on how to save on those prescriptions.

• High court weighs drug companies' generics policy

  By Jesse J. Holland and Linda A. Johnson, Associated Press  |  March 25, 2013

  The Supreme Court struggled Monday with whether it should allow federal officials to challenge deals between pharmaceutical corporations and their generic drug competitors that the government says could keep cheaper forms of medicine off the American market for longer periods of time.

• 

  High court weighs generic drug policies

  By Jesse J. Holland  |  March 25, 2013

  Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs. They argue these deals deny American consumers, usually for years, steep price declines that can top 90 percent.

• Feds plan to revise cigarette labels

  By Michael Felberbaum  |  March 19, 2013

  The U.S. government is abandoning a legal battle to require that cigarette packs carry a set of large and often macabre warning labels depicting the dangers of smoking and encouraging smokers to quit.

• 

  Bloomberg cigarette plan draws praise, criticism

  By Jennifer Peltz, Meghan Barr  |  March 19, 2013

  Anti-smoking advocates and health experts hailed proposals from Mayor Michael Bloomberg that would keep cigarettes out of sight in New York City stores, while tobacco companies and smokers called it an overreach.

• Arena slips as it waits for ruling on weight drug

  By Associated Press  |  March 4, 2013

  Arena Pharmaceuticals Inc. reported a smaller fourth-quarter loss Monday, but said it is still waiting for federal regulators to make a decision about the status of its weight loss drug Belviq.